Outcome of the Board Meeting held on 11.06.2025
IREDA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Midcap 150 and 0.9 pts more than its Financial Institution peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
IREDA's Board approved the allotment of 12.14 crore equity shares to qualified institutional buyers under a Qualified Institutions Placement (QIP) at ₹165.14 per share, aggregating to ₹2,005.90 crore. The issue price includes a premium of ₹155.14 over the face value of ₹10, but was set at a 5% discount (₹8.69) to the floor price determined under SEBI ICDR rules. Post-allotment, the company's paid-up equity capital has increased from ₹2,687.76 crore to ₹2,809.23 crore. Key allottees include LIC (50%), Morgan Stanley Asia Singapore (9.12%), Societe Generale (8.98%), and Vikasa India EIF I Fund (5.13%).
The QIP raises ₹2,005.90 crore of fresh equity capital for IREDA, strengthening its balance sheet for renewable energy financing. The allotment of 12.14 crore new shares (about 4.5% dilution) and the fact that marquee investors like LIC and Morgan Stanley took significant stakes could be viewed positively, though the 5% discount to floor price and near-term dilution may put mild pressure on the stock.